UMC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
United Microelectronics Corp (UMC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial growth and revenue increases, the current technical indicators and analyst sentiment suggest caution. The stock's recent downgrades, lack of strong upward momentum, and absence of proprietary trading signals make it more suitable for holding rather than immediate purchase.
The MACD is negatively expanding with a histogram of -0.136, indicating bearish momentum. RSI is at 26.086, which is neutral but leaning toward oversold territory. Moving averages are converging, showing no clear trend. The current price of $9.6 is near the S1 support level of $9.7, suggesting limited downside but also weak upward momentum.
UMC reported a 6.33% YoY revenue increase for February 2026 and a 5.81% rise in year-to-date revenue, indicating a rebound in semiconductor demand. The company's Q4 2025 financials showed strong growth in revenue (+6.66% YoY), net income (+23.32% YoY), and EPS (+50% YoY). Additionally, hedge funds have significantly increased their buying activity (+653.09% over the last quarter).
Analysts have downgraded the stock, citing concerns over weaker demand in the PC and smartphone segments and limited EPS growth potential. The stock has also seen a 1.85% pre-market decline and a 1.54% regular market drop, reflecting weak short-term sentiment. Technical indicators do not suggest a strong upward trend.
In Q4 2025, UMC achieved a revenue increase of 6.66% YoY, net income growth of 23.32% YoY, and a 50% YoY rise in EPS. Gross margin also improved slightly to 30.67%. February 2026 revenue grew by 6.33% YoY, and year-to-date revenue rose by 5.81%, indicating consistent financial performance.
Recent analyst ratings are mixed to negative. Daiwa downgraded UMC to Neutral with an increased price target of NT$59.50. KGI Securities upgraded it to Neutral with a NT$70 price target. BNP Paribas and JPMorgan downgraded the stock to Underperform and Underweight, respectively, citing concerns about demand and limited growth potential.
